Visual-spatial performance deficits in children with neurofibromatosis type-1

Neurofibromatosis type‐1 (NF1) is a common genetic disorder associated with a variety of medical complications, cognitive impairments, and behavioral problems including a high incidence of Attention Deficit Hyperactivity Disorder (ADHD). The current study examined the hypotheses that deficits in vis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of medical genetics 2003-07, Vol.120A (3), p.326-330
Hauptverfasser: Schrimsher, Gregory W., Billingsley, Rebecca L., Slopis, John M., Moore III, Bartlett D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 330
container_issue 3
container_start_page 326
container_title American journal of medical genetics
container_volume 120A
creator Schrimsher, Gregory W.
Billingsley, Rebecca L.
Slopis, John M.
Moore III, Bartlett D.
description Neurofibromatosis type‐1 (NF1) is a common genetic disorder associated with a variety of medical complications, cognitive impairments, and behavioral problems including a high incidence of Attention Deficit Hyperactivity Disorder (ADHD). The current study examined the hypotheses that deficits in visual–spatial/motor abilities enable one to discriminate and classify children with NF1 (n = 101) compared to control children (n = 37), beyond effects secondary to parent reported ADHD symptomology. Discriminant analysis showed a multivariate combination of visual–spatial/motor ability tests (Judgment of Line Orientation, Block Design subtest of the WISC‐III, Recognition–Discrimination Test, Beery Visual–Motor Integration Test) to be a significant predictor of NF1 diagnostic status (P = 0.0000004; canonical R2 = 0.2306). A significantly greater degree of ADHD behavior was found in the NF1 group, and a discriminant analysis using ADHD residualized visual–spatial motor scores indicated that the combination of tests continued to be a significant predictor of group membership after the level of ADHD behavior was controlled (P = 0.00002 and a canonical R2 = 0.1818). This combination of tests proved to be a strong discriminator of NF1. It correctly identified 90% of individuals with the diagnosis, and may be useful to educators to provide assistance and alternatives to minimize the impact of learning problems in those with either known or suspected NF1. © 2003 Wiley‐Liss, Inc.
doi_str_mv 10.1002/ajmg.a.20048
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73433855</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73433855</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4308-42b2b530737b2852480702ea9ed3f41c5d71b97d3fd8f4227ba19052ba45615c3</originalsourceid><addsrcrecordid>eNqFkMtP3DAQhy0EAkp744xygVOzjF9r54hWsG1Z4NKXerEmjgOGvLAT0f3vm-0ucIPTzEjf_EbzEXJIYUIB2Cne17cTnDAAobfIPpWSpUJzvv3SM7lHPsR4D8BBquku2aNMcy0l7JOrnz4OWKWxw95jlXQulG2osbEuKVzpre9j4pvE3vmqCK5Jnnx_lzRuCG3p89DW2LfRx6Rfdi6lH8lOiVV0nzb1gPy4OP8--5IubuZfZ2eL1AoOOhUsZ7nkoLjKmZZMaFDAHGau4KWgVhaK5pkah0KXgjGVI81AshyFnFJp-QE5Wed2oX0cXOxN7aN1VYWNa4doFBd89eC7IAOtMj6FEfy8Bm1oYwyuNF3wNYaloWBWns3Ks0Hz3_OIH21yh7x2xSu8ETsCxxsAo8WqDKNRH185kXEt-CqIr7knX7nlm0fN2ber-fP5dL3lY-_-vmxheDDTUao0v67n5ne2uMzYnwuz4P8AWnmkwQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20879360</pqid></control><display><type>article</type><title>Visual-spatial performance deficits in children with neurofibromatosis type-1</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Schrimsher, Gregory W. ; Billingsley, Rebecca L. ; Slopis, John M. ; Moore III, Bartlett D.</creator><creatorcontrib>Schrimsher, Gregory W. ; Billingsley, Rebecca L. ; Slopis, John M. ; Moore III, Bartlett D.</creatorcontrib><description>Neurofibromatosis type‐1 (NF1) is a common genetic disorder associated with a variety of medical complications, cognitive impairments, and behavioral problems including a high incidence of Attention Deficit Hyperactivity Disorder (ADHD). The current study examined the hypotheses that deficits in visual–spatial/motor abilities enable one to discriminate and classify children with NF1 (n = 101) compared to control children (n = 37), beyond effects secondary to parent reported ADHD symptomology. Discriminant analysis showed a multivariate combination of visual–spatial/motor ability tests (Judgment of Line Orientation, Block Design subtest of the WISC‐III, Recognition–Discrimination Test, Beery Visual–Motor Integration Test) to be a significant predictor of NF1 diagnostic status (P = 0.0000004; canonical R2 = 0.2306). A significantly greater degree of ADHD behavior was found in the NF1 group, and a discriminant analysis using ADHD residualized visual–spatial motor scores indicated that the combination of tests continued to be a significant predictor of group membership after the level of ADHD behavior was controlled (P = 0.00002 and a canonical R2 = 0.1818). This combination of tests proved to be a strong discriminator of NF1. It correctly identified 90% of individuals with the diagnosis, and may be useful to educators to provide assistance and alternatives to minimize the impact of learning problems in those with either known or suspected NF1. © 2003 Wiley‐Liss, Inc.</description><identifier>ISSN: 1552-4825</identifier><identifier>ISSN: 0148-7299</identifier><identifier>EISSN: 1552-4833</identifier><identifier>EISSN: 1096-8628</identifier><identifier>DOI: 10.1002/ajmg.a.20048</identifier><identifier>PMID: 12838550</identifier><identifier>CODEN: AJMGDA</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Analysis of Variance ; Attention Deficit Disorder with Hyperactivity - genetics ; Attention Deficit Disorder with Hyperactivity - physiopathology ; attention deficit-hyperactivity disorder ; Biological and medical sciences ; Child ; children ; Dermatology ; Female ; Hereditary diseases of the skin. Congenital diseases of the skin. Haemangioma of the skin, of mucosae and of soft tissue ; Humans ; Male ; Medical sciences ; Neurofibromatosis 1 - genetics ; Neurofibromatosis 1 - physiopathology ; neurofibromatosis type-1 ; Neurology ; Psychomotor Performance - physiology ; Spatial Behavior - physiology ; Tumors of the nervous system. Phacomatoses ; visual-motor ; visual-spatial</subject><ispartof>American journal of medical genetics, 2003-07, Vol.120A (3), p.326-330</ispartof><rights>Copyright © 2003 Wiley‐Liss, Inc.</rights><rights>2003 INIST-CNRS</rights><rights>Copyright 2003 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4308-42b2b530737b2852480702ea9ed3f41c5d71b97d3fd8f4227ba19052ba45615c3</citedby><cites>FETCH-LOGICAL-c4308-42b2b530737b2852480702ea9ed3f41c5d71b97d3fd8f4227ba19052ba45615c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fajmg.a.20048$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fajmg.a.20048$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14938438$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12838550$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schrimsher, Gregory W.</creatorcontrib><creatorcontrib>Billingsley, Rebecca L.</creatorcontrib><creatorcontrib>Slopis, John M.</creatorcontrib><creatorcontrib>Moore III, Bartlett D.</creatorcontrib><title>Visual-spatial performance deficits in children with neurofibromatosis type-1</title><title>American journal of medical genetics</title><addtitle>Am. J. Med. Genet</addtitle><description>Neurofibromatosis type‐1 (NF1) is a common genetic disorder associated with a variety of medical complications, cognitive impairments, and behavioral problems including a high incidence of Attention Deficit Hyperactivity Disorder (ADHD). The current study examined the hypotheses that deficits in visual–spatial/motor abilities enable one to discriminate and classify children with NF1 (n = 101) compared to control children (n = 37), beyond effects secondary to parent reported ADHD symptomology. Discriminant analysis showed a multivariate combination of visual–spatial/motor ability tests (Judgment of Line Orientation, Block Design subtest of the WISC‐III, Recognition–Discrimination Test, Beery Visual–Motor Integration Test) to be a significant predictor of NF1 diagnostic status (P = 0.0000004; canonical R2 = 0.2306). A significantly greater degree of ADHD behavior was found in the NF1 group, and a discriminant analysis using ADHD residualized visual–spatial motor scores indicated that the combination of tests continued to be a significant predictor of group membership after the level of ADHD behavior was controlled (P = 0.00002 and a canonical R2 = 0.1818). This combination of tests proved to be a strong discriminator of NF1. It correctly identified 90% of individuals with the diagnosis, and may be useful to educators to provide assistance and alternatives to minimize the impact of learning problems in those with either known or suspected NF1. © 2003 Wiley‐Liss, Inc.</description><subject>Analysis of Variance</subject><subject>Attention Deficit Disorder with Hyperactivity - genetics</subject><subject>Attention Deficit Disorder with Hyperactivity - physiopathology</subject><subject>attention deficit-hyperactivity disorder</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>children</subject><subject>Dermatology</subject><subject>Female</subject><subject>Hereditary diseases of the skin. Congenital diseases of the skin. Haemangioma of the skin, of mucosae and of soft tissue</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neurofibromatosis 1 - genetics</subject><subject>Neurofibromatosis 1 - physiopathology</subject><subject>neurofibromatosis type-1</subject><subject>Neurology</subject><subject>Psychomotor Performance - physiology</subject><subject>Spatial Behavior - physiology</subject><subject>Tumors of the nervous system. Phacomatoses</subject><subject>visual-motor</subject><subject>visual-spatial</subject><issn>1552-4825</issn><issn>0148-7299</issn><issn>1552-4833</issn><issn>1096-8628</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtP3DAQhy0EAkp744xygVOzjF9r54hWsG1Z4NKXerEmjgOGvLAT0f3vm-0ucIPTzEjf_EbzEXJIYUIB2Cne17cTnDAAobfIPpWSpUJzvv3SM7lHPsR4D8BBquku2aNMcy0l7JOrnz4OWKWxw95jlXQulG2osbEuKVzpre9j4pvE3vmqCK5Jnnx_lzRuCG3p89DW2LfRx6Rfdi6lH8lOiVV0nzb1gPy4OP8--5IubuZfZ2eL1AoOOhUsZ7nkoLjKmZZMaFDAHGau4KWgVhaK5pkah0KXgjGVI81AshyFnFJp-QE5Wed2oX0cXOxN7aN1VYWNa4doFBd89eC7IAOtMj6FEfy8Bm1oYwyuNF3wNYaloWBWns3Ks0Hz3_OIH21yh7x2xSu8ETsCxxsAo8WqDKNRH185kXEt-CqIr7knX7nlm0fN2ber-fP5dL3lY-_-vmxheDDTUao0v67n5ne2uMzYnwuz4P8AWnmkwQ</recordid><startdate>20030730</startdate><enddate>20030730</enddate><creator>Schrimsher, Gregory W.</creator><creator>Billingsley, Rebecca L.</creator><creator>Slopis, John M.</creator><creator>Moore III, Bartlett D.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20030730</creationdate><title>Visual-spatial performance deficits in children with neurofibromatosis type-1</title><author>Schrimsher, Gregory W. ; Billingsley, Rebecca L. ; Slopis, John M. ; Moore III, Bartlett D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4308-42b2b530737b2852480702ea9ed3f41c5d71b97d3fd8f4227ba19052ba45615c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Analysis of Variance</topic><topic>Attention Deficit Disorder with Hyperactivity - genetics</topic><topic>Attention Deficit Disorder with Hyperactivity - physiopathology</topic><topic>attention deficit-hyperactivity disorder</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>children</topic><topic>Dermatology</topic><topic>Female</topic><topic>Hereditary diseases of the skin. Congenital diseases of the skin. Haemangioma of the skin, of mucosae and of soft tissue</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neurofibromatosis 1 - genetics</topic><topic>Neurofibromatosis 1 - physiopathology</topic><topic>neurofibromatosis type-1</topic><topic>Neurology</topic><topic>Psychomotor Performance - physiology</topic><topic>Spatial Behavior - physiology</topic><topic>Tumors of the nervous system. Phacomatoses</topic><topic>visual-motor</topic><topic>visual-spatial</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schrimsher, Gregory W.</creatorcontrib><creatorcontrib>Billingsley, Rebecca L.</creatorcontrib><creatorcontrib>Slopis, John M.</creatorcontrib><creatorcontrib>Moore III, Bartlett D.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of medical genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schrimsher, Gregory W.</au><au>Billingsley, Rebecca L.</au><au>Slopis, John M.</au><au>Moore III, Bartlett D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Visual-spatial performance deficits in children with neurofibromatosis type-1</atitle><jtitle>American journal of medical genetics</jtitle><addtitle>Am. J. Med. Genet</addtitle><date>2003-07-30</date><risdate>2003</risdate><volume>120A</volume><issue>3</issue><spage>326</spage><epage>330</epage><pages>326-330</pages><issn>1552-4825</issn><issn>0148-7299</issn><eissn>1552-4833</eissn><eissn>1096-8628</eissn><coden>AJMGDA</coden><abstract>Neurofibromatosis type‐1 (NF1) is a common genetic disorder associated with a variety of medical complications, cognitive impairments, and behavioral problems including a high incidence of Attention Deficit Hyperactivity Disorder (ADHD). The current study examined the hypotheses that deficits in visual–spatial/motor abilities enable one to discriminate and classify children with NF1 (n = 101) compared to control children (n = 37), beyond effects secondary to parent reported ADHD symptomology. Discriminant analysis showed a multivariate combination of visual–spatial/motor ability tests (Judgment of Line Orientation, Block Design subtest of the WISC‐III, Recognition–Discrimination Test, Beery Visual–Motor Integration Test) to be a significant predictor of NF1 diagnostic status (P = 0.0000004; canonical R2 = 0.2306). A significantly greater degree of ADHD behavior was found in the NF1 group, and a discriminant analysis using ADHD residualized visual–spatial motor scores indicated that the combination of tests continued to be a significant predictor of group membership after the level of ADHD behavior was controlled (P = 0.00002 and a canonical R2 = 0.1818). This combination of tests proved to be a strong discriminator of NF1. It correctly identified 90% of individuals with the diagnosis, and may be useful to educators to provide assistance and alternatives to minimize the impact of learning problems in those with either known or suspected NF1. © 2003 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>12838550</pmid><doi>10.1002/ajmg.a.20048</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1552-4825
ispartof American journal of medical genetics, 2003-07, Vol.120A (3), p.326-330
issn 1552-4825
0148-7299
1552-4833
1096-8628
language eng
recordid cdi_proquest_miscellaneous_73433855
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Analysis of Variance
Attention Deficit Disorder with Hyperactivity - genetics
Attention Deficit Disorder with Hyperactivity - physiopathology
attention deficit-hyperactivity disorder
Biological and medical sciences
Child
children
Dermatology
Female
Hereditary diseases of the skin. Congenital diseases of the skin. Haemangioma of the skin, of mucosae and of soft tissue
Humans
Male
Medical sciences
Neurofibromatosis 1 - genetics
Neurofibromatosis 1 - physiopathology
neurofibromatosis type-1
Neurology
Psychomotor Performance - physiology
Spatial Behavior - physiology
Tumors of the nervous system. Phacomatoses
visual-motor
visual-spatial
title Visual-spatial performance deficits in children with neurofibromatosis type-1
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T01%3A36%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Visual-spatial%20performance%20deficits%20in%20children%20with%20neurofibromatosis%20type-1&rft.jtitle=American%20journal%20of%20medical%20genetics&rft.au=Schrimsher,%20Gregory%20W.&rft.date=2003-07-30&rft.volume=120A&rft.issue=3&rft.spage=326&rft.epage=330&rft.pages=326-330&rft.issn=1552-4825&rft.eissn=1552-4833&rft.coden=AJMGDA&rft_id=info:doi/10.1002/ajmg.a.20048&rft_dat=%3Cproquest_cross%3E73433855%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20879360&rft_id=info:pmid/12838550&rfr_iscdi=true